Page last updated: 2024-11-06

4-methylbenzylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

4-methylbenzylamine is a primary amine that is a colorless liquid with a pungent odor. It is used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals. It is also a precursor to various other compounds, such as the herbicide glyphosate. Research on 4-methylbenzylamine is ongoing, with a focus on its potential applications in various industries. It is studied for its potential role in the development of new drugs and catalysts. Its importance lies in its versatility and its potential to contribute to technological advancements in various fields.'

Cross-References

ID SourceID
PubMed CID66035
CHEMBL ID273483
SCHEMBL ID11699
MeSH IDM0175015

Synonyms (48)

Synonym
AC-17022
STL299663
nsc66562
4-methylbenzylamine ,
benzylamine, p-methyl-
p-methylbenzylamine
benzenemethanamine, 4-methyl-
nsc-66562
104-84-7
1-(4-methylphenyl)methanamine
inchi=1/c8h11n/c1-7-2-4-8(6-9)5-3-7/h2-5h,6,9h2,1h
4-methylbenzylamine, 97%
(4-methylphenyl)methanamine
p-tolylmethanamine
CHEMBL273483 ,
4-methyl-benzylamine
alpha-amino-p-xylene
M0864
AKOS000120767
nsc 66562
einecs 203-243-2
bdbm50408785
p-xylylamine
FT-0619072
PS-3250
SCHEMBL11699
4-methyl-benzyl amine
p-methyl benzyl amine
[(4-methylphenyl)methyl]amine
p-methyl benzylamine
4-methyl benzylamine
para-methylbenzylamine
4-methylbenzyl amine
p-methyl-benzylamine
4methylbenzylamine
DTXSID2059306
(4-methylphenyl)methanamine #
STR00200
W-108805
CS-W022218
F0798-0692
mfcd00008123
4-methylbenzylamine, purum, >=97.0% (gc)
D77926
02N ,
AM9932
Q27449791
EN300-16222
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Trypsin-1Homo sapiens (human)Ki666,807.00000.00001.76768.9000AID215915
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (5)

Processvia Protein(s)Taxonomy
digestionTrypsin-1Homo sapiens (human)
extracellular matrix disassemblyTrypsin-1Homo sapiens (human)
proteolysisTrypsin-1Homo sapiens (human)
methylationPhenylethanolamine N-methyltransferaseBos taurus (cattle)
epinephrine biosynthetic processPhenylethanolamine N-methyltransferaseBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
serine-type endopeptidase activityTrypsin-1Homo sapiens (human)
metal ion bindingTrypsin-1Homo sapiens (human)
phenylethanolamine N-methyltransferase activityPhenylethanolamine N-methyltransferaseBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
extracellular regionTrypsin-1Homo sapiens (human)
collagen-containing extracellular matrixTrypsin-1Homo sapiens (human)
blood microparticleTrypsin-1Homo sapiens (human)
extracellular spaceTrypsin-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID215915The compound was tested for inhibition of the proteolytic enzyme trypsin.1999Journal of medicinal chemistry, Dec-16, Volume: 42, Issue:25
Simple linear QSAR models based on quantum similarity measures.
AID273098Activity of mouse SSAO measured as hydrogen peroxide production at 100 uM relative to benzylamine oxidation2006Journal of medicinal chemistry, Oct-19, Volume: 49, Issue:21
New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking.
AID225081Inhibition of phenylethanolamine N-methyltransferase(PNMT)activity1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
Quantitative structure-activity relationships employing independent quantum chemical indices.
AID155317Acid dissociation constant of phenylethanolamine N-methyl-transferase (PNMT) inhibition1988Journal of medicinal chemistry, Feb, Volume: 31, Issue:2
Conformational and steric aspects of the inhibition of phenylethanolamine N-methyltransferase by benzylamines.
AID155316Molar pI50 value for phenylethanolamine N-methyl-transferase (PNMT) inhibition1988Journal of medicinal chemistry, Feb, Volume: 31, Issue:2
Conformational and steric aspects of the inhibition of phenylethanolamine N-methyltransferase by benzylamines.
AID273097Activity of human SSAO measured as hydrogen peroxide production at 1 mM relative to benzylamine oxidation2006Journal of medicinal chemistry, Oct-19, Volume: 49, Issue:21
New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (22.22)18.7374
1990's2 (22.22)18.2507
2000's3 (33.33)29.6817
2010's0 (0.00)24.3611
2020's2 (22.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.69 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index44.95 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (11.11%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]